| pubmed-article:9554653 | pubmed:abstractText | To review the pharmacology of the long-acting inhaled beta2-agonists, salmeterol and formoterol, summarize results of their clinical trials, evaluate their safety records, and discuss their roles in the treatment of asthma. | lld:pubmed |
